Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 325176, 10 pages
http://dx.doi.org/10.1155/2015/325176
Research Article

Clinicopathological Significance of MicroRNA-20b Expression in Hepatocellular Carcinoma and Regulation of HIF-1α and VEGF Effect on Cell Biological Behaviour

1Institute of General Surgical Research, Second Affiliated Hospital, Yangzhou University, Yangzhou, Jiangsu 225002, China
2Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China

Received 14 March 2015; Revised 31 August 2015; Accepted 15 September 2015

Academic Editor: Mohammad R. Abbaszadegan

Copyright © 2015 Tong-min Xue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” CA: A Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. S. Thorgeirsson and J. W. Grisham, “Molecular pathogenesis of human hepatocellular carcinoma,” Nature Genetics, vol. 31, no. 4, pp. 339–346, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Budhu, H.-L. Jia, M. Forgues et al., “Identification of metastasis-related microRNAs in hepatocellular carcinoma,” Hepatology, vol. 47, no. 3, pp. 897–907, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Chen, X. Zhao, and L. Ma, “Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma,” Molecular and Cellular Biochemistry, vol. 383, no. 1-2, pp. 49–58, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. L. He and G. J. Hannon, “MicroRNAs: small RNAs with a big role in gene regulation,” Nature Reviews Genetics, vol. 5, no. 7, pp. 522–531, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Nelson, M. Kiriakidou, A. Sharma, E. Maniataki, and Z. Mourelatos, “The microRNA world: small is mighty,” Trends in Biochemical Sciences, vol. 28, no. 10, pp. 534–540, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Chen, Q. Xi, Q. Wang, and P. Wei, “Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer,” Medical Oncology, vol. 31, article 235, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Ventura and T. Jacks, “MicroRNAs and cancer: short RNAs go a long way,” Cell, vol. 136, no. 4, pp. 586–591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. V. Iorio and C. M. Croce, “MicroRNAs in cancer: small molecules with a huge impact,” Journal of Clinical Oncology, vol. 27, no. 34, pp. 5848–5856, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Esquela-Kerscher and F. J. Slack, “Oncomirs—microRNAs with a role in cancer,” Nature Reviews Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Ambros, “The functions of animal microRNAs,” Nature, vol. 431, no. 7006, pp. 350–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Wang, J. Li, J. Shen, C. Wang, L. Yang, and X. Zhang, “MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma,” BMC Cancer, vol. 12, article 227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Braconi, J. C. Henry, T. Kogure, T. Schmittgen, and T. Patel, “The role of microRNAs in human liver cancers,” Seminars in Oncology, vol. 38, no. 6, pp. 752–763, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Negrini, L. Gramantieri, S. Sabbioni, and C. M. Croce, “microRNA involvement in hepatocellular carcinoma,” Anti-Cancer Agents in Medicinal Chemistry, vol. 11, no. 6, pp. 500–521, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. G. L. Semenza and G. L. Wang, “A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation,” Molecular and Cellular Biology, vol. 12, no. 12, pp. 5447–5454, 1992. View at Google Scholar · View at Scopus
  17. A. Weidemann and R. S. Johnson, “Biology of HIF-1alpha,” Cell Death and Differentiation, vol. 15, no. 4, pp. 621–627, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. G. L. Semenza, “Targeting HIF-1 for cancer therapy,” Nature Reviews Cancer, vol. 3, no. 10, pp. 721–732, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. Q. Ke and M. Costa, “Hypoxia-inducible factor-1 (HIF-1),” Molecular Pharmacology, vol. 70, no. 5, pp. 1469–1480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Hong, H. Lee, and K. W. Kim, “HIF-1α: a valid therapeutic target for tumor therapy,” Cancer Research and Treatment, vol. 36, no. 6, pp. 343–353, 2004. View at Publisher · View at Google Scholar
  21. S. K. Burroughs, S. Kaluz, D. Wang, K. Wang, E. G. Van Meir, and B. Wang, “Hypoxia inducible factor pathway inhibitors as anticancer therapeutics,” Future Medicinal Chemistry, vol. 5, no. 5, pp. 553–572, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Ferrara and R. S. Kerbel, “Angiogenesis as a therapeutic target,” Nature, vol. 438, no. 7070, pp. 967–974, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. D. J. Hicklin and L. M. Ellis, “Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis,” Journal of Clinical Oncology, vol. 23, no. 5, pp. 1011–1027, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Luo, Z. Wang, J. Wu, C. Jiang, and J. Wu, “The role of hypoxia inducible factor-1 in hepatocellular carcinoma,” BioMed Research International, vol. 2014, Article ID 409272, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. T.-H. Cheung, K.-N. M. Man, M.-Y. Yu et al., “Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm,” Cell Cycle, vol. 11, no. 15, pp. 2876–2884, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Katada, H. Ishiguro, Y. Kuwabara et al., “MicroRNA expression profile in undifferentiated gastric cancer,” International Journal of Oncology, vol. 34, no. 2, pp. 537–542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Lei, B. Li, Z. Yang et al., “Regulation of HIF-1α and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration,” PLoS ONE, vol. 4, no. 10, Article ID e7629, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Zhou, G. Shi, Q. Zhang, Q. Wu, B. Li, and Z. Zhang, “MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN),” Cell & Bioscience, vol. 4, article 62, 2014. View at Publisher · View at Google Scholar
  29. J. Ingwersen, T. Menge, B. Wingerath et al., “Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b,” Annals of Clinical and Translational Neurology, vol. 2, no. 1, pp. 43–55, 2015. View at Publisher · View at Google Scholar
  30. T. Yamaguchi, T. Iijima, R. Wakaume et al., “Underexpression of miR-126 and miR-20b in hereditary and nonhereditary colorectal tumors,” Oncology, vol. 87, no. 1, pp. 58–66, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Zhu, L. Chen, L. Zou et al., “MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer,” Human Immunology, vol. 75, no. 4, pp. 348–353, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Saleiban, L. Faxälv, K. Claesson, J.-I. Jönsson, and A. Osman, “miR-20b regulates expression of proteinase-activated receptor-1 (PAR-1) thrombin receptor in melanoma cells,” Pigment Cell and Melanoma Research, vol. 27, no. 3, pp. 431–441, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. J.-Y. Li, Y. Zhang, W.-H. Zhang, S. Jia, Y. Kang, and X.-Y. Zhu, “Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 5, pp. 1901–1906, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Cascio, A. D'Andrea, R. Ferla et al., “miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells,” Journal of Cellular Physiology, vol. 224, no. 1, pp. 242–249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. C.-J. Wang, Z.-G. Zhou, L. Wang et al., “Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer,” Disease Markers, vol. 26, no. 1, pp. 27–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Martinez-Fernandez, Z. Pons, M. Margalef, A. Arola-Arnal, and B. Muguerza, “Regulation of vascular endothelial genes by dietary flavonoids: structure-expression relationship studies and the role of the transcription factor KLF-2,” Journal of Nutritional Biochemistry, vol. 26, pp. 277–284, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. Y.-H. Yu, D.-S. Wu, F.-F. Huang et al., “MicroRNA-20b and ERK1/2 pathway independently regulate the expression of tissue factor in hematopoietic and trophoblastic differentiation of human embryonic stem cells,” Stem Cell Research and Therapy, vol. 4, article 121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Sasabe, Y. Tatemoto, D. Li, T. Yamamoto, and T. Osaki, “Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells,” Cancer Science, vol. 96, no. 7, pp. 394–402, 2005. View at Publisher · View at Google Scholar
  39. M. Xu, Y.-L. Zheng, X.-Y. Xie et al., “Sorafenib blocks the HIF-1α/VEGFA pathway, inhibits tumor invasion, and induces apoptosis in hepatoma cells,” DNA and Cell Biology, vol. 33, no. 5, pp. 275–281, 2014. View at Publisher · View at Google Scholar · View at Scopus